Initially built out of 10 years investment in the Wellcome Sanger Institute, Microbiotica has unrivalled capabilities in microbiome analysis linked to patient phenotype. It is a global leader in gut bacterial culturing, and has a world leading microbiome Culture Collection, proprietary Reference Genome Database and advanced microbiome bioinformatics. The company also has advanced capabilities in microbiome/host biology and preclinical development of bacterial products. Microbiotica has a pipeline of highly differentiated clinically-derived products including Live Bacterial Therapeutics and Biomarkers in IBD, Immuno-oncology and Gut Epithelial Barrier Repair. It has collaborations with Cancer Research UK and Cambridge University Hospitals in Immuno-oncology, Genentech/Roche in IBD, and University of Adelaide in Ulcerative Colitis.
Looking for a particular Microbiotica employee's phone or email?
Microbiotica Questions
The Microbiotica annual revenue was $5 million in 2026.
Tim Sharpington is the CEO of Microbiotica.
37 people are employed at Microbiotica.
The NAICS codes for Microbiotica are [541, 54, 5417, 54171, 541713].
The SIC codes for Microbiotica are [873, 87].
Top Microbiotica Employees
-
Tim Sharpington
Chief Executive Officer at Microbiotica
Cambridge, GB1 -
Robert Tansley
Chief Medical Officer at Microbiotica
Cambridge, Cambridgeshire, United Kingdom5 -
Matthew Robinson
SVP Research at Microbiotica
Cambridge, MA, US1 -
2
-
Simon Harris
Vice President Informatics at Microbiotica
United Kingdom1 -
Emma Hames
Senior Director, CMC at Microbiotica
Little Chesterford, England, GB2 -
11
-
Anne Neville
Director at Microbiotica
Cambridge, GB1
Related Companies
